# Gordon J. Freeman

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/gordon-j-freeman/

## Facts

| Field | Value |
| --- | --- |
| Citations | 132,839 |
| Field | Cancer Immunotherapy and Biomarkers |
| h-index | 176 |
| i10-index | 422 |
| Last Known Institution | Harvard University |
| OpenAlex ID | https://openalex.org/A5075310347 |
| ORCID iD | https://orcid.org/0000-0002-7210-5616 |
| Works | 1,093 |

## Researcher papers

- [Adaptive resistance to therapeutic PD-1 blockade is associated with upregulation of alternative immune checkpoints](https://scholariq.org/papers/adaptive-resistance-to-therapeutic-pd-1-blockade-is-associated-with-upregulation/)
- [Activation of the PD-1 Pathway Contributes to Immune Escape in EGFR-Driven Lung Tumors](https://scholariq.org/papers/activation-of-the-pd-1-pathway-contributes-to-immune-escape-in-egfr-driven-lung/)
- [CDK4/6 Inhibition Augments Antitumor Immunity by Enhancing T-cell Activation](https://scholariq.org/papers/cdk4-6-inhibition-augments-antitumor-immunity-by-enhancing-t-cell-activation/)
- [<i>Fusobacterium nucleatum</i>and T Cells in Colorectal Carcinoma](https://scholariq.org/papers/i-fusobacterium-nucleatum-i-and-t-cells-in-colorectal-carcinoma/)
- [STK11/LKB1 Deficiency Promotes Neutrophil Recruitment and Proinflammatory Cytokine Production to Suppress T-cell Activity in the Lung Tumor Microenvironment](https://scholariq.org/papers/stk11-lkb1-deficiency-promotes-neutrophil-recruitment-and-proinflammatory/)
- [<i>Ex Vivo</i> Profiling of PD-1 Blockade Using Organotypic Tumor Spheroids](https://scholariq.org/papers/i-ex-vivo-i-profiling-of-pd-1-blockade-using-organotypic-tumor-spheroids/)
- [Loss of Lkb1 and Pten Leads to Lung Squamous Cell Carcinoma with Elevated PD-L1 Expression](https://scholariq.org/papers/loss-of-lkb1-and-pten-leads-to-lung-squamous-cell-carcinoma-with-elevated-pd-l1/)
- [Therapeutically Increasing MHC-I Expression Potentiates Immune Checkpoint Blockade](https://scholariq.org/papers/therapeutically-increasing-mhc-i-expression-potentiates-immune-checkpoint/)

## Researcher topics

- [Cancer Immunotherapy and Biomarkers](https://scholariq.org/topics/cancer-immunotherapy-and-biomarkers/)
- [Immune Cell Function and Interaction](https://scholariq.org/topics/immune-cell-function-and-interaction/)
- [Immunotherapy and Immune Responses](https://scholariq.org/topics/immunotherapy-and-immune-responses/)
- [CAR-T cell therapy research](https://scholariq.org/topics/car-t-cell-therapy-research/)
- [T-cell and B-cell Immunology](https://scholariq.org/topics/t-cell-and-b-cell-immunology/)

## Researcher university

- [Harvard University](https://scholariq.org/institutions/harvard-university/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.